Yelloweyes Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-12-2024
- Paid Up Capital ₹ 0.50 M
as on 24-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit -1795.37%
(FY 2020)
- Ebitda -2618.05%
(FY 2020)
- Net Worth -11.44%
(FY 2020)
- Total Assets 69.53%
(FY 2020)
About Yelloweyes Biotech
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Varma, Anand Singh, Rovin Parmar, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100UP2018PTC109843
- Company No.
109843
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Yelloweyes Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Varma  | Director | 06-Jun-2019 | Current |
| Anand Singh | Director | 20-Jan-2020 | Current |
| Rovin Parmar | Director | 29-Oct-2018 | Current |
| Madhulika Singh | Additional Director | 20-Jan-2020 | Current |
Financial Performance of Yelloweyes Biotech.
Yelloweyes Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1795.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yelloweyes Biotech?
Unlock access to Yelloweyes Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Forum For Industrial Skill Enhancement & TrainingActive 6 years 8 months
Rovin Parmar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yelloweyes Biotech?
Unlock and access historical data on people associated with Yelloweyes Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yelloweyes Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yelloweyes Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
